Discover Community Create You

t/oximes

Oximes

Discuss literature indexed with the corpus topic “Oximes”.

0 followers0 posts487 articles

Create Post

TitleDiscussionLink a PMID (optional)

All posts discussion question review note

Create the first post

Ask a question, share an idea or link scientific evidence.

Topic rules

Follow Noodle’s community and scientific integrity rules.

Moderators

Managed by the Noodle moderation team.

Related literature

Hydrogel microtumor arrays of patient melanoma recapitulate phenotypes and drug sensitivity.
Oximes
Programmable bioprinting of tumor microenvironment arrays reveals laminin-dependent drug sensitivity
Oximes
Evaluating the Cost-Effectiveness of Dabrafenib and Trametinib for the Treatment of Pediatric Patients With a BRAF V600E Mutation Low-Grade Glioma in England and Wales.
Oximes
ETI corrector therapy suppresses mitochondrial respiration independently of CFTR mutational status.
Oximes
[Treatment with dabrafenib and trametinib in an intrahepatic cholangiocarcinoma harboring a BRAF V600E mutation].
Oximes
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.
Oximes
Liquid Biopsy Monitoring in BRAF V600E-Mutated Patients With Non-Small Cell Lung Cancer Treated With Dabrafenib Plus Trametinib: The Prospective, Multicenter LiBRA Study (GOIRC-03-2020).
Oximes
Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF/MEK inhibitors in papillary craniopharyngioma: a report of two cases.
Oximes
BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.
Oximes
Lesional dosimetry in 131I refractory metastatic differentiated thyroid cancer with BRAFp.V600E or RAS mutation treated with trametinib +/- dabrafenib followed by radioactive iodine.
Oximes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details